Earnings Feed
Start Free
PMV Pharmaceuticals, Inc.·4

Jan 22, 4:02 PM ET

Mack David Henry 4

4 · PMV Pharmaceuticals, Inc. · Filed Jan 22, 2024

Insider Transaction Report

Form 4
Period: 2024-01-18
PMV Pharmaceuticals, Inc.PMVP
Mack David Henry
DirectorPresident and CEO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2024-01-18+519,915→ 519,915 total
    Exercise: $1.80Exp: 2034-01-18→ Common Stock (519,915 underlying)
  • Award

    Common Stock

    2024-01-18+163,890→ 442,460 total
Holdings

  • Common Stock

    (indirect: See footnote)
    56,978

  • Common Stock

    (indirect: See footnote)
    165,307

  • Common Stock

    (indirect: See footnote)
    147,915
Footnotes (4)
  • [F1]The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 30, 2025.
  • [F2]The shares are held of record by the Stinson 2021 Irrevocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
  • [F3]The shares are held of record by The Mack-Mulligan Revocable Trust. The reporting person disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
  • [F4]Shares subject to the option vest in 48 equal monthly installments beginning on February 18, 2024.

Documents

2 files